Naomi Arnold takes another look at our alarming death rate from synthetic cannabinoids and at some real-world responses from people working at the frontline.
Dr Sam McBride counters that the evidence isn’t all that compelling and that the risks are not yet fully clear – despite the naïve naturalist claims of some of its proponents.
Dr David Caldicott argues that the evidence for its effectiveness seems real and that we should get on with exploring a medicinal regime in the interests of patient wellbeing.
Concerns were raised about a West Auckland school using a MethHelp booklet in the classroom. This was a good thing to do.
Hear directly from the lead author of the Chief Science Advisor's report on third hard exposure to methamphetamine.
Tangi Noomotu suggests we need to take a good hard look at how much those working in the addiction field are asking of tangata whaiora.
Canadian Centre on Substance Use and Addiction's CEO explains what cannabis legalisation might mean for mean for society, young people and public health.
There is no clear picture of what question will appear on the cannabis referendum ballot. The details are important, argues Russell Brown.
Until recently Norway has been wed to conservative drug law. This looks like it will change in a recent, sudden and surprising turn of events.
KnowYourStuffNZ have analysed results from drug checking they offered at several festivals around NZ over the summer. Read a summary of the results.
Some Māori enterprises are gearing up to win a share of the medicinal cannabis market when the law is changed. Two enterprises tell their story.
Te Ara Oranga pilot putting more support in place for people using methamphetamine and their whānau is already proving its worth. What next?